Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.
Biomarker and diagnostic research for disseminated intravascular coagulation has been reported in the published literature.
1 FDA-approved treatment is available for disseminated intravascular coagulation, including HEPARIN SODIUM (HEPARIN SODIUM, approved 2011).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
10 clinical trials registered, 1 recruiting. Interventions under study include other interventions, drug therapy, and biologic therapy. Pipeline includes 2 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06854640](https://clinicaltrials.gov/study/NCT06854640) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:43 PM UTC
HEPARIN SODIUM
HEPARIN SODIUM |
— |
2011 |
Available |
HEPARIN SODIUM AND DEXTROSE | HEPARIN SODIUM | — | 1985 | Available |
Gene therapy approaches for disseminated intravascular coagulation have been reported in the published literature.
10 trials found
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
PHASE1 |
Bayer |
RECRUITING |
376 publications have been identified in PubMed for disseminated intravascular coagulation. Kisho has analyzed 260 by research type. Research spans Review / Meta-Analysis (26%), Case Report / Case Series (20%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 68 | 26% |
Patient case studies | 52 | 20% |
Disease patterns and progression | 47 | 18% |
Clinical study results | 38 | 15% |
Laboratory research | 27 | 10% |
Testing and diagnosis research | 24 | 9% |
New treatment approaches | 3 | 1% |
Other research | 1 | 0% |
Okada H (2026). [PMID: 41489428](https://pubmed.ncbi.nlm.nih.gov/41489428/). *Critical care medicine*. [Clinical Trial Publication]
Turcato G (2026). [PMID: 41289648](https://pubmed.ncbi.nlm.nih.gov/41289648/). *Thrombosis research*. [Epidemiology / Natural History]
Tschirhart M (2026). [PMID: 41788491](https://pubmed.ncbi.nlm.nih.gov/41788491/). *Annals of intensive care*. [Review / Meta-Analysis]
Saleem MY (2026). [PMID: 41742167](https://pubmed.ncbi.nlm.nih.gov/41742167/). *Thrombosis journal*. [Clinical Trial Publication]
Abdul Gafoor SM (2026). [PMID: 40795257](https://pubmed.ncbi.nlm.nih.gov/40795257/). *Clinical and experimental dermatology*. [Review / Meta-Analysis]
Hayamizu M (2026). [PMID: 41679708](https://pubmed.ncbi.nlm.nih.gov/41679708/). *Thrombosis and haemostasis*. [Epidemiology / Natural History]
Gan J (2026). [PMID: 41574949](https://pubmed.ncbi.nlm.nih.gov/41574949/). *Shock*. [Diagnostic / Biomarker]
Saquib Alam M (2026). [PMID: 41791773](https://pubmed.ncbi.nlm.nih.gov/41791773/). *BMJ Case Rep*. [Case Report / Case Series]
Pham HT (2026). [PMID: 41869175](https://pubmed.ncbi.nlm.nih.gov/41869175/). *Cureus*. [Case Report / Case Series]
Munira S (2026). [PMID: 41914104](https://pubmed.ncbi.nlm.nih.gov/41914104/). *Mymensingh medical journal : MMJ*. [Epidemiology / Natural History]
AI-curated news mentioning disseminated intravascular coagulation
Updated May 6, 2026
A case study details Capnocytophaga canimorsus septicaemia leading to multiorgan dysfunction syndrome and disseminated intravascular coagulation in an immunocompetent patient. This highlights the potential severity of infections caused by this bacterium.
A recent case study highlights the challenges in diagnosing canine diffuse microscopic pancreatic adenocarcinoma, which presented with normal imaging and gross appearance of the pancreas. The case was further complicated by sterile peritonitis and disseminated intravascular coagulation, emphasizing the need for improved diagnostic techniques.
A case report details a rare instance of catastrophic antiphospholipid syndrome presenting with eosinophilia, which can mimic hypereosinophilic syndromes and lead to disseminated intravascular coagulation. This finding may enhance understanding of the complexities in diagnosing these overlapping conditions.